Disclosure Statement
Disclosure of Food and Drug Administration (FDA) Status
Continuing Education (CE) activities may include discussion of investigational or “off-label” use of drugs or medical devices. Although the ACS encourages CE course authors to disclose such “off-label” uses, it is the responsibility of each physician to be aware of the approval status of drugs and devices before using them in his/her clinical practice. Any such discussion of investigational drugs or medical devices will be clearly indicated in the course article unless otherwise noted.
Disclosure of Editor and Nurse Planner Relationships
Ted Gansler, MD, MBA, Editor, CE Director, and ACS Director of Medical Content, reports that he has no financial relationships or interests to disclose.
Marcia Grant, RN, DNSc, FAAN, Nursing CE Nurse Planner, reports that she has no financial relationships or interests to disclose.
Disclosure of Author Relationships
It is the policy of the American Cancer Society to assure that its educational mission, and Continuing Education activities in particular, should not be influenced by the special interests of individuals associated with these programs. Having an interest in, or an affiliation with, any corporate organization does not necessarily influence an author’s course, but the relationship will be made known in the course article, in advance, to the course participants in accordance with the Standards of the Accreditation Council for Continuing Medical Education.
The ACS requires CE course authors to sign a declaration disclosing any significant relationships related directly or indirectly to their course content that might be reasonably perceived as a potential conflict of interest. This includes financial interests, arrangements, or affiliations with companies or other organizations whose products or services are discussed in the activity. Any such disclosures by the authors of CE courses are indicated as notes on the title page of the course article.
Disclosure of Commercial Support
The ACS CE program may receive financial support for some CE activities in the form of an unrestricted educational grant. Any such support for a CE activity will be prominently and clearly disclosed in advance to participants. The ACS CE program staff and the Continuing Education Advisory Committee will review such programs to assure that discussion of data regarding products of a company providing the education grant are objectively selected and presented, with favorable and unfavorable information and balanced discussion of prevailing information on their products and any alternative products.
Copyright © 2008 by the American Cancer Society.